UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Journal of hepatology, 2017-02, Vol.66 (2), p.282-287

2017

Volltextzugriff (PDF)

HCV-Therapie – Die unterschiedliche Preisentwicklung in Europa

Zeitschrift für Gastroenterologie, 2016-07, Vol.54 (7), p.701-702

2016

Volltextzugriff (PDF)

Prescription of new HCV-drugs - what has to be considered judicially

Zeitschrift fur Gastroenterologie, 2015-01, Vol.53 (1), p.43

Mauss, Stefan

2015

Volltextzugriff (PDF)

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1405-1411

2016

Volltextzugriff (PDF)

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Clinical infectious diseases, 2013, Vol.57

2013

Volltextzugriff (PDF)

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

Journal of hepatology, 2017-07, Vol.67 (1), p.15-22

2017

Volltextzugriff (PDF)

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68 (4), p.663-671

2018

Volltextzugriff (PDF)

Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study

HIV medicine, 2024-10

2024

Volltextzugriff (PDF)

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Liver international, 2021-05, Vol.41 (5), p.949-955

2021

Volltextzugriff (PDF)

Sicherheit vor Regressen – Wirtschaftlichkeit in der Verordnung der Hepatitis C-Therapie

Zeitschrift für Gastroenterologie, 2015-07, Vol.53 (7), p.742-745

2015

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Volltextzugriff (PDF)

Therapy of HIV-HBV-coinfection

MMW Fortschritte der Medizin, 2009-04, Vol.151 (18), p.49

Mauss, Stefan

2009

Volltextzugriff (PDF)

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e607-e612

2023

Volltextzugriff (PDF)

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2022-07, Vol.77, p.S562-S563

2022

Volltextzugriff (PDF)

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1320-1324

2016

Volltextzugriff (PDF)

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Liver international, 2020-03, Vol.40 (3), p.539-548

2020

Volltextzugriff (PDF)

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Journal of hepatology, 2022-07, Vol.77, p.S16

2022

Volltextzugriff (PDF)

Recommendations for the management of hepatitis C virus infection among people who inject drugs

The International journal of drug policy, 2015-10, Vol.26 (10), p.1028-1038

2015

Volltextzugriff (PDF)

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl 2), p.S129-S137

2013

Volltextzugriff (PDF)

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Journal of viral hepatitis, 2021-10, Vol.28 (10), p.1474-1483

2021

Volltextzugriff (PDF)

Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110

2014

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110

2014

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2014-09, Vol.60 (3), p.1110-1110

2014

Volltextzugriff (PDF)

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

The Journal of infectious diseases, 2019-10, Vol.220 (10), p.1635-1644

2019

Volltextzugriff (PDF)

Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B

Journal of hepatology, 2011-12, Vol.55 (6), p.1235-1240

2011

Volltextzugriff (PDF)

26 – 50 von 203

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionSpringerLink (Online service)

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)

Publikationsform

Sprache

Englisch
(181)
Deutsch
(23)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(101)
Science & Technology
(101)
Humans
(91)
Male
(63)
Female
(58)
Adult
(56)
Middle Aged
(54)
Infectious Diseases
(50)
Gastroenterology & Hepatology
(49)
Antiviral Agents - Therapeutic Use
(47)
Hepatitis C
(37)
Hepatitis C, Chronic - Drug Therapy
(35)
Gastroenterology And Hepatology
(34)
Hepatitis
(29)
Drug Therapy, Combination
(28)
Hiv
(27)
Aged
(26)
Biological And Medical Sciences
(25)
Human Immunodeficiency Virus
(24)
Treatment Outcome
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

HCV-Therapie – Die unterschiedliche Preisentwicklung in Europa

Prescription of new HCV-drugs - what has to be considered judicially

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010–2015

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Sicherheit vor Regressen – Wirtschaftlichkeit in der Verordnung der Hepatitis C-Therapie

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Therapy of HIV-HBV-coinfection

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir

Reply

Reply

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B

Aktive Filter

Suchergebnisse filtern